Copyright Reports & Markets. All rights reserved.

Global Tumor Ablation Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Tumor Ablation Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Tumor Ablation Market Size Growth Rate by Product
      • 1.4.2 Radiofrequency (RF) Ablation
      • 1.4.3 Microwave Ablation
      • 1.4.4 Cryoablation
      • 1.4.5 Other Technologies
    • 1.5 Market by End User
      • 1.5.1 Global Tumor Ablation Market Size Growth Rate by End User
      • 1.5.2 Liver Cancer
      • 1.5.3 Lung Cancer
      • 1.5.4 Kidney Cancer
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Tumor Ablation Market Size
      • 2.1.1 Global Tumor Ablation Revenue 2014-2025
      • 2.1.2 Global Tumor Ablation Sales 2014-2025
    • 2.2 Tumor Ablation Growth Rate by Regions
      • 2.2.1 Global Tumor Ablation Sales by Regions
      • 2.2.2 Global Tumor Ablation Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Tumor Ablation Sales by Manufacturers
      • 3.1.1 Tumor Ablation Sales by Manufacturers
      • 3.1.2 Tumor Ablation Sales Market Share by Manufacturers
      • 3.1.3 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tumor Ablation Revenue by Manufacturers
      • 3.2.1 Tumor Ablation Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tumor Ablation Revenue Share by Manufacturers (2014-2019)
    • 3.3 Tumor Ablation Price by Manufacturers
    • 3.4 Tumor Ablation Manufacturing Base Distribution, Product Types
      • 3.4.1 Tumor Ablation Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Tumor Ablation Product Type
      • 3.4.3 Date of International Manufacturers Enter into Tumor Ablation Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Tumor Ablation Sales by Product
    • 4.2 Global Tumor Ablation Revenue by Product
    • 4.3 Tumor Ablation Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Tumor Ablation Breakdown Data by End User

    6 North America

    • 6.1 North America Tumor Ablation by Countries
      • 6.1.1 North America Tumor Ablation Sales by Countries
      • 6.1.2 North America Tumor Ablation Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Tumor Ablation by Product
    • 6.3 North America Tumor Ablation by End User

    7 Europe

    • 7.1 Europe Tumor Ablation by Countries
      • 7.1.1 Europe Tumor Ablation Sales by Countries
      • 7.1.2 Europe Tumor Ablation Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Tumor Ablation by Product
    • 7.3 Europe Tumor Ablation by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Tumor Ablation by Countries
      • 8.1.1 Asia Pacific Tumor Ablation Sales by Countries
      • 8.1.2 Asia Pacific Tumor Ablation Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Tumor Ablation by Product
    • 8.3 Asia Pacific Tumor Ablation by End User

    9 Central & South America

    • 9.1 Central & South America Tumor Ablation by Countries
      • 9.1.1 Central & South America Tumor Ablation Sales by Countries
      • 9.1.2 Central & South America Tumor Ablation Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Tumor Ablation by Product
    • 9.3 Central & South America Tumor Ablation by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Tumor Ablation by Countries
      • 10.1.1 Middle East and Africa Tumor Ablation Sales by Countries
      • 10.1.2 Middle East and Africa Tumor Ablation Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Tumor Ablation by Product
    • 10.3 Middle East and Africa Tumor Ablation by End User

    11 Company Profiles

    • 11.1 Angiodynamics
      • 11.1.1 Angiodynamics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Angiodynamics Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Angiodynamics Tumor Ablation Products Offered
      • 11.1.5 Angiodynamics Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Tumor Ablation Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 Boston Scientific
      • 11.3.1 Boston Scientific Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Boston Scientific Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Boston Scientific Tumor Ablation Products Offered
      • 11.3.5 Boston Scientific Recent Development
    • 11.4 Galil Medical
      • 11.4.1 Galil Medical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Galil Medical Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Galil Medical Tumor Ablation Products Offered
      • 11.4.5 Galil Medical Recent Development
    • 11.5 Neuwave Medical
      • 11.5.1 Neuwave Medical Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Neuwave Medical Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Neuwave Medical Tumor Ablation Products Offered
      • 11.5.5 Neuwave Medical Recent Development
    • 11.6 Misonix
      • 11.6.1 Misonix Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Misonix Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Misonix Tumor Ablation Products Offered
      • 11.6.5 Misonix Recent Development
    • 11.7 Merit Medical
      • 11.7.1 Merit Medical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merit Medical Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merit Medical Tumor Ablation Products Offered
      • 11.7.5 Merit Medical Recent Development
    • 11.8 Sonacare Medical
      • 11.8.1 Sonacare Medical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Sonacare Medical Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Sonacare Medical Tumor Ablation Products Offered
      • 11.8.5 Sonacare Medical Recent Development
    • 11.9 EDAP TMS
      • 11.9.1 EDAP TMS Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 EDAP TMS Tumor Ablation Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 EDAP TMS Tumor Ablation Products Offered
      • 11.9.5 EDAP TMS Recent Development

    12 Future Forecast

    • 12.1 Tumor Ablation Market Forecast by Regions
      • 12.1.1 Global Tumor Ablation Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Tumor Ablation Revenue Forecast by Regions 2019-2025
    • 12.2 Tumor Ablation Market Forecast by Product
      • 12.2.1 Global Tumor Ablation Sales Forecast by Product 2019-2025
      • 12.2.2 Global Tumor Ablation Revenue Forecast by Product 2019-2025
    • 12.3 Tumor Ablation Market Forecast by End User
    • 12.4 North America Tumor Ablation Forecast
    • 12.5 Europe Tumor Ablation Forecast
    • 12.6 Asia Pacific Tumor Ablation Forecast
    • 12.7 Central & South America Tumor Ablation Forecast
    • 12.8 Middle East and Africa Tumor Ablation Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Tumor Ablation Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Tumor Ablation market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tumor Ablation market based on company, product type, end user and key regions.

      This report studies the global market size of Tumor Ablation in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tumor Ablation in these regions.
      This research report categorizes the global Tumor Ablation market by top players/brands, region, type and end user. This report also studies the global Tumor Ablation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Angiodynamics
      Medtronic
      Boston Scientific
      Galil Medical
      Neuwave Medical
      Misonix
      Merit Medical
      Sonacare Medical
      EDAP TMS

      Market size by Product
      Radiofrequency (RF) Ablation
      Microwave Ablation
      Cryoablation
      Other Technologies
      Market size by End User
      Liver Cancer
      Lung Cancer
      Kidney Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Tumor Ablation market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Tumor Ablation market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Tumor Ablation companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Tumor Ablation submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Tumor Ablation are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tumor Ablation market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now